AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 6 analysts
Fundamentals
Fundamentals institutional score is 98 using growth durability 97.7.
Valuation
Valuation institutional score is 46 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 75 using mean target upside 30.4%; dispersion penalty 20.2; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 91 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is skewing constructive on impact and recency. Based on 1 recent ticker-linked news items.
Signal Summary
Market intelligence remains Supportive. fundamentals and analyst consensus provide support, while valuation remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 14.3% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +1.07). Confidence: 82%.
Live forward EPS implies next-12-month EPS of ₹30.23. Applying the stock's normalized valuation corridor produces a fair range of ₹791.42 to ₹1,094.33, with base value near ₹1,005.45 (+35.5% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹30.23
Forward P/E
24.5x
Base Fair Value
₹1,005.45
Fair Range
₹791.42 - ₹1,094.33
Upside To Base
+35.5%
Estimate Source
Live forward EPS
Growth Estimate
+40.6%
5Y Average
29.20
Current
38.02
Overvalued
36.20
Undervalued
26.18
5Y Average
15.22
Current
19.86
Overvalued
18.35
Undervalued
12.67
5Y Average
3.58
Current
3.75
Overvalued
4.11
Undervalued
3.04
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.9x Undervalued | -58% vs avg | -4.3% |
FINE ORGANIC IND. LTD. FINEORGSpecialty Chemicals | +22.1% | 17.8% | 36.9x Undervalued | -43% vs avg | +5.6% |
CLEAN SCIENCE & TECH LTD CLEANSpecialty Chemicals | +10.5% | 23.7% | 36.6x Undervalued | -43% vs avg | -32.3% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.6x Undervalued | -57% vs avg | -14.4% |
AETHER INDUSTRIES LIMITED AETHERSpecialty Chemicals | +27.5% | 19.1% | 89.6x Premium | +39% vs avg | +117.0% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.8x Premium | +23% vs avg | +6.7% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 53.0x Undervalued | -18% vs avg | +71.4% |
NEOGEN CHEMICALS LIMITED NEOGENSpecialty Chemicals | +34.0% | 3.8% | 165.2x Premium | +157% vs avg | +42.6% |
JUBILANT INGREVIA LIMITED trades at a discount (38.1x vs peer avg 64.3x), suggesting potential undervaluation relative to the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, FINE ORGANIC IND. LTD., CLEAN SCIENCE & TECH LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹1.25K CrJun 2026Latest net profit
₹126 CrJun 2026Latest EPS
₹7.92Jun 2026Net margin
17.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,031 | 1,003 | 917 | 1,037 | 969 | 1,005 | 995 | 972 | 973 | 1,054 | 1,018 | 1,093 | 1,253 |
| Expenses + | 917 | 882 | 843 | 943 | 881 | 878 | 864 | 844 | 852 | 953 | 906 | 956 | 1,039 |
| Operating Profit | 114 | 121 | 74 | 94 | 88 | 128 | 131 | 128 | 121 | 101 | 112 | 138 | 214 |
| OPM % | 11% | 12% | 8% | 9% | 9% | 13% | 13% | 13% | 12% | 10% | 11% | 13% | 17% |
| Other Income + | 10 | 8 | 8 | 10 | 9 | 9 | 27 | 36 | 11 | 11 | 20 | 46 | 11 |
| Interest | 15 | 16 | 18 | 17 | 17 | 17 | 15 | 16 | 15 | 14 | 15 | 13 | 14 |
| Depreciation | 32 | 33 | 34 | 35 | 36 | 37 | 37 | 37 | 38 | 39 | 42 | 43 | 41 |
| Profit before tax | 77 | 80 | 30 | 52 | 44 | 82 | 106 | 111 | 79 | 59 | 75 | 128 | 170 |
| Tax % | 29% | 28% | 36% | 41% | 26% | 27% | 24% | 19% | 26% | 26% | 21% | 18% | 26% |
| Net Profit + | 55 | 57 | 19 | 31 | 33 | 60 | 81 | 90 | 59 | 44 | 60 | 105 | 126 |
| EPS in Rs | 3.44 | 3.60 | 1.21 | 1.94 | 2.06 | 3.78 | 5.06 | 5.64 | 3.70 | 2.76 | 3.75 | 6.61 | 7.92 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation